Summer 1988: I am sitting at a larg...

Summer 1988: I am sitting at a large colloquy table in the Worldwide Business unfolding Department at E.R. Squibb & Son Pharmaceuticals. In my first position in the industry, I have been charged with creating a 35-mm slide point out to help promote Squibb to potential business evolution partners. This is a novel idea at the time: chiefly pharmaceutical companies do not perceive a ne to market themselves in order to in-license desirable of the present day products.

In fact, the industry at this time is flush with modern products: 20 new molecular entities (NMEs) will be approved this year.